Spinal Tech

Here are two spine and orthopedic company transactions in the past month:

AcelRX Pharmaceuticals is partnering with Brigham and Women's Hospital in Boston to study the perioperative use of DSUVIA in the analgesic regimen for spine surgery.

The FDA provided Medacta clearance for its Mecta-C Stand Alone anterior cervical fusion device.

A royalties dispute between Medtronic and Carmel-based Indiana Spine Group founder Rick Sasso, MD, was returned to a state court March 4, The Indiana Lawyer reports.

Osteobiologics company Biogennix received FDA clearance March 5 for an expanded indication of its Agilon moldable bone grafting product.

The minimally invasive spinal implant market has growth in its sights, with the market projected to hit $6.49 billion by 2027, according to analysis by Reports and Data.

Here are nine key notes on spine and orthopedic device companies:

Biopharmaceutical company DiscGenics recently finished enrollment for its clinical trial of IDCT, an allogeneic, injectable disc cell therapy for degenerative disc disease.

Implanet recently appointed Stephan Collardey as country manager of its German subsidiary Implanet GmbH to accelerate its commercial and business operations.

The FDA on March 3 granted Life Spine 510(k) clearance for its Lateral Prolift Expandable System.